SCHEMBL17412541

SCHEMBL17412541

CC1(C)OB(c2ccc(-c3nc(-c4ccccc4)c4ccccc4n3)c3ccccc23)OC1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ATM Q13315 1/20 0.44
▸ NUDT1 P36639 3/20 0.43
▸ ADORA2A P29274 4/20 0.39
▸ LPL P06858 1/20 0.39
▸ LIPG Q9Y5X9 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ MAPT P10636 3/20 0.37
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ WHR1 P49842 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ RAD52 P43351 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27360056 0.89 MEN1 (0.45) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL27296257 0.86 MEN1 (0.39) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL29927412 0.85 LPL (0.44) MEN1KMT2AATMADORA2ALPL
SCHEMBL18347059 0.85 LPL (0.44) MEN1KMT2AATMADORA2ALPL
SCHEMBL23327871 0.85 LIPG (0.54) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL20699264 0.84 LPL (0.43) MEN1KMT2AATMADORA2ALPL
SCHEMBL17412531 0.84 LIPG (0.35) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL26654318 0.83 LPL (0.42) MEN1KMT2AATMADORA2ALPL
SCHEMBL24149672 0.83 MEN1 (0.51) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL17412542 0.83 MEN1 (0.42) MEN1KMT2AATMNUDT1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed
CN-112262144-A Compound, organic electroluminescent device and display device SK材料有限公司 2021-01-22 — — CN disclosed
WO-2016003225-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2016-01-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 MEN1 2723/4885KMT2A 2958/4885ATM 4383/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 MEN1 2723/4885KMT2A 2958/4885ATM 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback